If you like to begin your day by wolfing down a breakfast burrito or breakfast sandwich from New Mexico’s best-known fast ...

From the ongoing political and legal battles over NHI, to the far-reaching health impacts of political change in the United States, it is set to be another tumultuous year for healthcare in South ...

Meanwhile, follow-up GLP-1 agonist Ozempic (semaglutide) has shown encouraging results in a phase 3 trial, and its once-weekly dosing may encourage greater take-up. Novo Nordisk applied to the FDA ...

LOS ANGELES (KTLA) – With the devastating Palisades Fire still smoldering, Lisa Pelton and some of her neighbors in ...

WASHINGTON, Jan 21 - The Trump administration said on Tuesday it was reinstating the "remain in Mexico" program, resuming an initiative that forced non-Mexican asylum seekers to wait in Mexico for ...

The US-Mexico border is effectively closed off to migrants seeking asylum in the United States within hours of President Donald Trump taking office, an extraordinary departure from previous ...

The president reiterated his plan during his inaugural address Monday. Among the first executive orders signed by President Donald Trump was an order to rename the Gulf of Mexico to the newly ...

The weight loss drug semaglutide was a "miracle" for Staci Rice. Her cravings and "food noise" disappeared, and it help her lose 64 pounds in around eight months. But, even in its cheaper forms ...

Mexico's annual inflation rate slowed to its lowest level in almost four years in the first half of January, official data showed on Thursday, a price level likely to encourage the central bank to ...

A Wisconsin teen set fire to a local Republican congressman’s office Sunday in a fit of rage over the TikTok ban, authorities ...

Semaglutide Injections: Popular choices for weight management. Regenerative medicine is unlocking new possibilities in both aesthetics and wellness, utilising the body’s own resources to restore ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...